Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On?
Strong Bullish
88.5
Neuronetics Inc. (NASDAQ:STIM) shares soared 41.08% to $2.06 in after-hours trading on Tuesday following preliminary fourth-quarter 2025 financial results.
Revenue Climbs Across Both Segments
The medical technology company reported fourth-quarter 2025 revenue of $41.8 million, up 23% on an adjusted pro forma basis and 86% compared with fourth-quarter 2024 on an as-reported basis.
Revenue from the NeuroStar system, the first transcranial magnetic stimulation (TMS) device to receive Food and Drug Administration clearance, was $18.3 million, up 9% pro forma, while clinic revenue reached $23.5 million, up 37% pro forma.
According to the company, it shipped 49 NeuroStar Advanced Therapy systems and generated positive operating cash flow of $0.9 million during the quarter, in line with previousl
Revenue Climbs Across Both Segments
The medical technology company reported fourth-quarter 2025 revenue of $41.8 million, up 23% on an adjusted pro forma basis and 86% compared with fourth-quarter 2024 on an as-reported basis.
Revenue from the NeuroStar system, the first transcranial magnetic stimulation (TMS) device to receive Food and Drug Administration clearance, was $18.3 million, up 9% pro forma, while clinic revenue reached $23.5 million, up 37% pro forma.
According to the company, it shipped 49 NeuroStar Advanced Therapy systems and generated positive operating cash flow of $0.9 million during the quarter, in line with previousl
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
